Presentation is loading. Please wait.

Presentation is loading. Please wait.

Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome  Richard M. Turner,

Similar presentations


Presentation on theme: "Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome  Richard M. Turner,"— Presentation transcript:

1 Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome  Richard M. Turner, MB BChir, Peng Yin, PhD, Anita Hanson, BSc, Richard FitzGerald, MB ChB, Andrew P. Morris, PhD, Rod H. Stables, DM, Andrea L. Jorgensen, PhD, Munir Pirmohamed, PhD  Journal of Clinical Lipidology  Volume 11, Issue 1, Pages (January 2017) DOI: /j.jacl Copyright © 2017 National Lipid Association Terms and Conditions

2 Figure 1 A schematic of the study selection process.
Journal of Clinical Lipidology  , DOI: ( /j.jacl ) Copyright © 2017 National Lipid Association Terms and Conditions

3 Figure 2 Cumulative survival curves. The cumulative survival curves compared suboptimal statin (green) and constant statin use (blue) group survival free from; (A) major adverse cardiovascular events (MACE) and (B) all-cause mortality (ACM). Survival curves plotted until last event occurrence. (Color version of figure is available online.) Journal of Clinical Lipidology  , DOI: ( /j.jacl ) Copyright © 2017 National Lipid Association Terms and Conditions


Download ppt "Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome  Richard M. Turner,"

Similar presentations


Ads by Google